Harvard Bioscience (HBIO) vs Rapid Micro Biosystems (RPID)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Harvard Bioscience (HBIO) has outperformed Rapid Micro Biosystems (RPID) over the past year, gaining 84.8% versus a loss of 75.4%. Over five years, HBIO leads with a -88.1% price change compared with -94.9% for RPID. Rapid Micro Biosystems is the larger company by market cap ($43.2 million vs $37.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HBIO | RPID |
|---|---|---|
| Share price | $8.13 | $0.8617 |
| Market cap | $37.01M | $43.22M |
| 1-day change | -4.35% | -4.01% |
| YTD return | +21.34% | -70.29% |
| 1-year return | +84.77% | -75.38% |
| 5-year return | -88.11% | -94.88% |
| Forward P/E | 12.60 | — |
| EPS (TTM) | $-2.31 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.40 | $4.94 |
| 52-week low | $3.80 | $0.826 |
| Distance from 52-week high | -13.51% | -82.56% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | -7.75% | +567.29% |
| Average volume | 17.98K | 271.93K |
| Shares outstanding | 4.55M | 45.66M |
| Employees | 316 | 171 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HBIO has outperformed RPID by 160.2 percentage points over the past year.
About Harvard Bioscience
HBIO stock →Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.
Healthcare · Medical Instruments & Supplies · 316 employees
About Rapid Micro Biosystems
RPID stock →Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Healthcare · Medical Devices · 171 employees
HBIO vs RPID FAQ
Which is bigger, Harvard Bioscience or Rapid Micro Biosystems?
Rapid Micro Biosystems (RPID) is larger, with a market capitalization of $43.22M compared with $37.01M for Harvard Bioscience (HBIO).
Which stock has performed better over the past year, HBIO or RPID?
HBIO returned +84.77% over the past 12 months, compared with -75.38% for RPID (price return, excluding dividends). Past performance does not predict future results.
Are Harvard Bioscience and Rapid Micro Biosystems in the same industry?
Both are in the Healthcare sector, but in different industries: Medical Instruments & Supplies for Harvard Bioscience and Medical Devices for Rapid Micro Biosystems.